Stay updated on Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial
Sign up to get notified when there's something new on the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page.

Latest updates to the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. This change appears to be a UI/version label update and does not modify the study results or core content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check30 days agoChange DetectedMean (Standard Error) values for NEWS2 changes over multiple days were added, with corresponding participant counts per arm. This provides additional statistical detail for interpreting secondary outcomes.SummaryDifference1%

- Check44 days agoChange DetectedRevision updated to v3.4.2, replacing the previous Revision: v3.4.1.SummaryDifference0.0%

- Check51 days agoChange DetectedThis is a minor site version update: Revision v3.4.1 was added and Revision v3.4.0 removed, with no changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded a glossary toggle and QC status indicators (First Submitted that Met QC Criteria, Results First Submitted that Met QC Criteria, Last Update Submitted that Met QC Criteria) along with a Revision: v3.4.0 tag. Removed No FEAR Act Data and the older Revision: v3.3.4 tag.SummaryDifference0.1%

Stay in the know with updates to Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page.